Appeal could throw spanner in the works for Regeneron’s Irish expansion

pharmafile | March 9, 2018 | News story | Manufacturing and Production, Medical Communications Ireland, Regeneron, pharma 

Regeneron is facing a single man-sized obstacle in plans to expand operations at its campus in Limerick, Ireland with a new €20 million bulk biologics facility which could see delays of up to half a year.  

One Michael Fenton has applied to independent Irish judicial body An Bord Pleanála to appeal the green light given by Limerick County Council. He did not object to the plans earlier in the process when the project was put before the council.  

The US firm originally announced the plans in October last year. It has stated that the expansion will create 150 new permanent roles, made up of those from the local area as well as people relocating back to Ireland. Additionally, the company said that 137 roles would be created in the service industry, while the three-year construction project to build the new site would employ another 500 people.

The board is due to make a decision on the matter by the end of March, and it could mean the project could be delayed by four to six months if the ruling comes down on the side of Mr Fenton.

Matt Fellows

Related Content

Pfizer sign

Delayed Pfizer vaccine dose gives 3.5 times more immunity, study shows

The Pfizer-BioNTech COVID-19 vaccine is around three and a half times more effective when dosed …

Amgen flag

AstraZeneca and Amgen asthma drug shows positive results in Phase III trial

AstraZeneca and Amgen’s new tezepelumab drug for the treatment of severe asthma has shown superiority …

India report record number of COVID deaths as bodies drift down Ganges

India yesterday reported the country’s highest COVID-19 death total for a single day, with 4,205 …

Latest content